Pacira BioSciences agrees to Viatris merger deal
Pacira BioSciences entered a definitive merger agreement with Viatris and a Viatris subsidiary. The subsidiary plans to launch a cash tender offer for all Pacira shares at $36.50 each, followed by a merger if conditions are met.